The Quality Control Manager applies extensive knowledge of clinical radiopharmaceuticals to ensure the quality of investigational radiopharmaceuticals specified by the standards stated in the USP Chapter and the laboratory requirements of 21 CFR 212. This position will report to the Director of the Radiopharmaceutical Facility in the development of quality control standard operating procedures for the investigational PET drugs such that the facilities, equipment, and inventory control meet the associated regulatory requirements. This position will also assist in creating new approaches in the quality control of novel radiopharmaceuticals for clinical use, and in working with the director in writing investigational drug applications (IND) and Abbreviated New Drug